Compare Amphastar Pharmaceuticals Inc (AMPH) vs Corsair Gaming Inc (CRSR) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Corsair Gaming (CRSR) surged 35.25% to $14.35, driven by strong Q2 2026 earnings that beat expectations and raised full-year guidance. The stock is in a bullish technical trend, trading near resistance at $15.00, with RSI indicating overbought conditions. Revenue was $1.47 billion in 2025, with net income improving to a projected $37 million profit in 2026, though margins remain slim. Recent news highlights growth in AI and sim racing segments, including the Trak Racer acquisition.

Outlook is positive due to earnings momentum and strategic expansions, but risks include high valuation (P/E 46.37) and competitive pressures. Analysts are mixed with a $12.40 consensus target, suggesting caution after the rally. Key opportunities lie in margin improvement and AI product adoption, while volatility and execution challenges pose near-term risks.